| Literature DB >> 28295493 |
Ken Washio1,2, Mayuko Sumi2, Kaori Nakata2, Atsushi Fukunaga2, Keiji Yamana3, Tsubasa Koda3, Ichiro Morioka3, Chikako Nishigori2, Kiyofumi Yamanishi4.
Abstract
Harlequin ichthyosis (HI) is the most severe form of autosomal recessive congenital ichthyosis, with a high mortality rate. Recent advances in neonatal care and the early administration of retinoids have improved the survival rate of HI. Here, we present a case of HI who was successfully treated with early administration of etretinate and showed good prognosis. Next-generation sequencing identified novel mutations of the ATP-binding cassette subfamily A member 12 gene (ABCA12), c.5884+4_+5delAA and c.7239G>A, which caused skipping of exons 39 and 48, respectively. Transcripts with exon 48 skipping, which cause a deletion in the second ATP-binding cassette of ABCA12, were dominantly expressed in the skin. Besides the early administration of etretinate, the differential expression of the mutant protein with limited segmental deletion of ABCA12 may be related to the favorable outcome of our patient.Entities:
Keywords: alternative splicing; autosomal recessive congenital ichthyosis; etretinate; harlequin ichthyosis; human ABCA12 protein
Mesh:
Substances:
Year: 2017 PMID: 28295493 DOI: 10.1111/1346-8138.13823
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005